| Dr Jorge Martin Paulino, MD | |
|
200 Hawthorne Ln, Charlotte, NC 28204-2515 | |
| (704) 384-5514 | |
| (704) 384-5992 |
| Full Name | Dr Jorge Martin Paulino |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 35 Years |
| Location | 200 Hawthorne Ln, Charlotte, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841397866 | NPI | - | NPPES |
| 8913256 | Medicaid | NC | |
| 802471 | Other | NC | PARTNERS MEDICARE |
| 34D0242865 | Other | NC | CLIA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Novant Health Presbyterian Medical Center | Charlotte, NC | Hospital |
| Spartanburg Medical Center | Spartanburg, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Novant Medical Group Inc | 1153234893 | 1996 |
| Spartanburg Medical Center | 3072425297 | 843 |
News Archive
The day of the week on which a patient has a lung cancer operation has no significance for their survival. This has been demonstrated by researchers at Karolinska Institutet in a new study published in the journal Chest.
The health divide between the most affluent and the worst off in society increases in later life, finds a study published on bmj.com.
How are non-heterosexual people affected by discrimination endured in the school environment due to their affective-sexual orientation? This question was the starting point in the PhD thesis produced by the researcher Aitor Martxueta.
Enobia Pharma today announced positive data from a clinical study of ENB-0040, a bone targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). After six months of treatment with ENB-0040, four of five severely affected patients showed marked improvements in bone mineralization, correction of skeletal defects, better respiratory function, including weaning from assisted ventilation, and cognitive and motor development.
› Verified 3 days ago
| Entity Name | Novant Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366409492 PECOS PAC ID: 1153234893 Enrollment ID: O20031121000692 |
News Archive
The day of the week on which a patient has a lung cancer operation has no significance for their survival. This has been demonstrated by researchers at Karolinska Institutet in a new study published in the journal Chest.
The health divide between the most affluent and the worst off in society increases in later life, finds a study published on bmj.com.
How are non-heterosexual people affected by discrimination endured in the school environment due to their affective-sexual orientation? This question was the starting point in the PhD thesis produced by the researcher Aitor Martxueta.
Enobia Pharma today announced positive data from a clinical study of ENB-0040, a bone targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). After six months of treatment with ENB-0040, four of five severely affected patients showed marked improvements in bone mineralization, correction of skeletal defects, better respiratory function, including weaning from assisted ventilation, and cognitive and motor development.
› Verified 3 days ago
| Entity Name | Caromont Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356314272 PECOS PAC ID: 3577476258 Enrollment ID: O20031201000070 |
News Archive
The day of the week on which a patient has a lung cancer operation has no significance for their survival. This has been demonstrated by researchers at Karolinska Institutet in a new study published in the journal Chest.
The health divide between the most affluent and the worst off in society increases in later life, finds a study published on bmj.com.
How are non-heterosexual people affected by discrimination endured in the school environment due to their affective-sexual orientation? This question was the starting point in the PhD thesis produced by the researcher Aitor Martxueta.
Enobia Pharma today announced positive data from a clinical study of ENB-0040, a bone targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). After six months of treatment with ENB-0040, four of five severely affected patients showed marked improvements in bone mineralization, correction of skeletal defects, better respiratory function, including weaning from assisted ventilation, and cognitive and motor development.
› Verified 3 days ago
| Entity Name | Cogent Healthcare Of North Carolina Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548207483 PECOS PAC ID: 7911954714 Enrollment ID: O20050404001057 |
News Archive
The day of the week on which a patient has a lung cancer operation has no significance for their survival. This has been demonstrated by researchers at Karolinska Institutet in a new study published in the journal Chest.
The health divide between the most affluent and the worst off in society increases in later life, finds a study published on bmj.com.
How are non-heterosexual people affected by discrimination endured in the school environment due to their affective-sexual orientation? This question was the starting point in the PhD thesis produced by the researcher Aitor Martxueta.
Enobia Pharma today announced positive data from a clinical study of ENB-0040, a bone targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). After six months of treatment with ENB-0040, four of five severely affected patients showed marked improvements in bone mineralization, correction of skeletal defects, better respiratory function, including weaning from assisted ventilation, and cognitive and motor development.
› Verified 3 days ago
| Entity Name | Vidant Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477648731 PECOS PAC ID: 0345343893 Enrollment ID: O20070321000445 |
News Archive
The day of the week on which a patient has a lung cancer operation has no significance for their survival. This has been demonstrated by researchers at Karolinska Institutet in a new study published in the journal Chest.
The health divide between the most affluent and the worst off in society increases in later life, finds a study published on bmj.com.
How are non-heterosexual people affected by discrimination endured in the school environment due to their affective-sexual orientation? This question was the starting point in the PhD thesis produced by the researcher Aitor Martxueta.
Enobia Pharma today announced positive data from a clinical study of ENB-0040, a bone targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). After six months of treatment with ENB-0040, four of five severely affected patients showed marked improvements in bone mineralization, correction of skeletal defects, better respiratory function, including weaning from assisted ventilation, and cognitive and motor development.
› Verified 3 days ago
| Entity Name | Hospitalist Medicine Physicians Of North Carolina Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164724902 PECOS PAC ID: 0143409185 Enrollment ID: O20110124000754 |
News Archive
The day of the week on which a patient has a lung cancer operation has no significance for their survival. This has been demonstrated by researchers at Karolinska Institutet in a new study published in the journal Chest.
The health divide between the most affluent and the worst off in society increases in later life, finds a study published on bmj.com.
How are non-heterosexual people affected by discrimination endured in the school environment due to their affective-sexual orientation? This question was the starting point in the PhD thesis produced by the researcher Aitor Martxueta.
Enobia Pharma today announced positive data from a clinical study of ENB-0040, a bone targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). After six months of treatment with ENB-0040, four of five severely affected patients showed marked improvements in bone mineralization, correction of skeletal defects, better respiratory function, including weaning from assisted ventilation, and cognitive and motor development.
› Verified 3 days ago
| Entity Name | Apogee Medical Group North Carolina |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043518228 PECOS PAC ID: 7719162254 Enrollment ID: O20110427000840 |
News Archive
The day of the week on which a patient has a lung cancer operation has no significance for their survival. This has been demonstrated by researchers at Karolinska Institutet in a new study published in the journal Chest.
The health divide between the most affluent and the worst off in society increases in later life, finds a study published on bmj.com.
How are non-heterosexual people affected by discrimination endured in the school environment due to their affective-sexual orientation? This question was the starting point in the PhD thesis produced by the researcher Aitor Martxueta.
Enobia Pharma today announced positive data from a clinical study of ENB-0040, a bone targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). After six months of treatment with ENB-0040, four of five severely affected patients showed marked improvements in bone mineralization, correction of skeletal defects, better respiratory function, including weaning from assisted ventilation, and cognitive and motor development.
› Verified 3 days ago
| Entity Name | Mission Health Community Multispecialty Providers Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457719130 PECOS PAC ID: 9537468574 Enrollment ID: O20160426001883 |
News Archive
The day of the week on which a patient has a lung cancer operation has no significance for their survival. This has been demonstrated by researchers at Karolinska Institutet in a new study published in the journal Chest.
The health divide between the most affluent and the worst off in society increases in later life, finds a study published on bmj.com.
How are non-heterosexual people affected by discrimination endured in the school environment due to their affective-sexual orientation? This question was the starting point in the PhD thesis produced by the researcher Aitor Martxueta.
Enobia Pharma today announced positive data from a clinical study of ENB-0040, a bone targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). After six months of treatment with ENB-0040, four of five severely affected patients showed marked improvements in bone mineralization, correction of skeletal defects, better respiratory function, including weaning from assisted ventilation, and cognitive and motor development.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jorge Martin Paulino, MD 10111 Whiteburn Ct, Charlotte, NC 28278-6638 Ph: (704) 527-5737 | Dr Jorge Martin Paulino, MD 200 Hawthorne Ln, Charlotte, NC 28204-2515 Ph: (704) 384-5514 |
News Archive
The day of the week on which a patient has a lung cancer operation has no significance for their survival. This has been demonstrated by researchers at Karolinska Institutet in a new study published in the journal Chest.
The health divide between the most affluent and the worst off in society increases in later life, finds a study published on bmj.com.
How are non-heterosexual people affected by discrimination endured in the school environment due to their affective-sexual orientation? This question was the starting point in the PhD thesis produced by the researcher Aitor Martxueta.
Enobia Pharma today announced positive data from a clinical study of ENB-0040, a bone targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). After six months of treatment with ENB-0040, four of five severely affected patients showed marked improvements in bone mineralization, correction of skeletal defects, better respiratory function, including weaning from assisted ventilation, and cognitive and motor development.
› Verified 3 days ago
Shakuntala Mathapati, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1000 Blythe Blvd, Charlotte, NC 28203 Phone: 704-355-0720 | |
Nicole A. Cagle Richardson, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 1001 Blythe Blvd, Medical Center Plaza Suite 200, Charlotte, NC 28203 Phone: 704-381-8840 | |
David Jerret Pubantz, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 4501 Cameron Valley Pkwy, Ste 200-b, Charlotte, NC 28211 Phone: 704-381-0500 | |
Joshua Lee Eichenberger, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1000 Blythe Blvd, Charlotte, NC 28203 Phone: 704-355-0720 | |
Stefanie Rose Reed, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 1001 Blythe Blvd, Medical Center Plaza Suite 200, Charlotte, NC 28203 Phone: 704-381-8840 | |
Jasdip G. Bajaj, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8800 N Tryon St, Charlotte, NC 28262 Phone: 704-863-6241 | |
Thanigaiarsu Thiyagarajan, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1100 Blythe Blvd, Charlotte, NC 28203 Phone: 704-355-4475 |